p53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints.
- Published in:
- Oncogene, 1999, v. 18, n. 20, p. 3135, doi. 10.1038/sj.onc.1202386
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 1999 AND VI 18 AND IP 20
Results: 16
1
2
DNA-PK, the DNA-activated protein kinase, is differentially expressed in normal and malignant human tissues.
- Published in:
- Oncogene, 1999, v. 18, n. 20, p. 3114, doi. 10.1038/sj.onc.1202640
- By:
- Publication type:
- Article
3
DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression.
- Published in:
- Oncogene, 1999, v. 18, n. 20, p. 3152, doi. 10.1038/sj.onc.1202641
- By:
- Publication type:
- Article
4
Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis.
- Published in:
- Oncogene, 1999, v. 18, n. 20, p. 3098, doi. 10.1038/sj.onc.1202642
- By:
- Publication type:
- Article
5
Cell specific transformation by c-fms activating loop mutations is attributable to constitutive receptor degradation.
- Published in:
- Oncogene, 1999, v. 18, n. 20, p. 3076, doi. 10.1038/sj.onc.1202646
- By:
- Publication type:
- Article
6
Sustained MAP kinase activation is required for the expression of cyclin D1, p21<sup>Cip1</sup> and a subset of AP-1 proteins in CCL39 cells.
- Published in:
- Oncogene, 1999, v. 18, n. 20, p. 3085, doi. 10.1038/sj.onc.1202647
- By:
- Publication type:
- Article
7
Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma.
- Published in:
- Oncogene, 1999, v. 18, n. 20, p. 3127, doi. 10.1038/sj.onc.1202648
- By:
- Publication type:
- Article
8
Disabled-2 inactivation is an early step in ovarian tumorigenicity.
- Published in:
- Oncogene, 1999, v. 18, n. 20, p. 3104, doi. 10.1038/sj.onc.1202649
- By:
- Publication type:
- Article
9
Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein.
- Published in:
- Oncogene, 1999, v. 18, n. 20, p. 3166, doi. 10.1038/sj.onc.1202650
- By:
- Publication type:
- Article
10
Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene.
- Published in:
- Oncogene, 1999, v. 18, n. 20, p. 3159, doi. 10.1038/sj.onc.1202651
- By:
- Publication type:
- Article
11
The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun.
- Published in:
- Oncogene, 1999, v. 18, n. 20, p. 3143, doi. 10.1038/sj.onc.1202654
- By:
- Publication type:
- Article
12
PTEN/MMAC1 mutations in hepatocellular carcinomas.
- Published in:
- Oncogene, 1999, v. 18, n. 20, p. 3181, doi. 10.1038/sj.onc.1202659
- By:
- Publication type:
- Article
13
Functional localization of a melanoma tumor suppressor gene to a small (2 Mb) region on 11q23.
- Published in:
- Oncogene, 1999, v. 18, n. 20, p. 3173, doi. 10.1038/sj.onc.1202664
- By:
- Publication type:
- Article
14
Erratum.
- Published in:
- 1999
- Publication type:
- Correction Notice
15
Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
- Published in:
- Oncogene, 1999, v. 18, n. 20, p. 3071, doi. 10.1038/sj.onc.1202879
- By:
- Publication type:
- Article
16
Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα.
- Published in:
- Oncogene, 1999, v. 18, n. 20, p. 3063, doi. 10.1038/sj.onc.1202893
- By:
- Publication type:
- Article